D+816
Today is 2024. 12. 08

Scientific Program

  • Home
  • Program
  • Scientific Program

※Some lectures will be pre-recorded.

September 17(Sat)
09:00 - 09:40
Plenary Lecture 4
September 17(Sat) 09:00 - 09:40
Plenary Lecture 4

Chairperson

Joong-Yeol Park (University of Ulsan, Korea)

09:00 - 09:40

Effect of alirocumab in subjects with likely familial hypercholesterolemia or type III hyperlipidemia: analyses from the ODYSSEY outcomes study

Sergio Fazio (Regeneron Pharmaceuticals, USA)

September 17(Sat)
09:45 - 11:15
Symposium 16
Current issues in severe dyslipidemia
September 17(Sat) 09:45 - 11:15
Symposium 16 Current issues in severe dyslipidemia

Chairpersons

최경묵 (고려의대), 강현재 (서울의대)

Panels

곽수헌 (서울의대), 변영섭 (인제의대)

09:45 - 10:05

What is currently best & changing in treatment of adults with FH?

이원재 (서울의대)

10:05 - 10:25

Update on familial vs multifactorial chylomicronemia syndrome (CS)

진흥용 (전북의대)

10:25 - 10:45

Understanding role of ANGPTL3 & neighbor molecules

박훈준 (가톨릭의대)

10:45 - 11:10

Discussion

September 17(Sat)
11:25 - 12:05
Plenary Lecture 5
September 17(Sat) 11:25 - 12:05
Plenary Lecture 5

Chairperson

Ki Hoon Han (University of Ulsan, Korea)

11:25 - 12:05

Best approach to cardio & cerebrovascular health in older people

Hidenori Arai (National Center for Geriatrics and Gerontology, Japan)

September 17(Sat)
13:00 - 13:30
Plenary Lecture 6 (APSAVD:Yamamoto Lecture)
September 17(Sat) 13:00 - 13:30
Plenary Lecture 6 (APSAVD:Yamamoto Lecture)

Chairperson

Richard O’Brien (University of Melbourne, Australia)

13:00 - 13:30

Up close & personal with vascular diseases: the role of precision medicine

Maria Teresa Abola (University of Philippines, Philippines)

September 17(Sat)
13:35 - 14:35
Oral Presentation 4
September 17(Sat) 13:35 - 14:35
Oral Presentation 4

Chairperson

허경선 (충남대)

Panels

박세은(성균관의대), 서미혜(순천향의대)

13:35 - 13:42

Evaluation of the paradoxical association between lipid levels & incident atrial fibrillation according to statin usage: a nationwide cohort study 

안효정 (서울의대)

13:42 - 13:49

Comparison of cerebro-cardiovascular prognosis between cholesterol exposure estimate & cholesterol variability 

주형준 (고려의대)

13:49 - 13:56

Early change in glucose level & risk of new-onset diabetes in patients initiating statin treatment

김충기 (이화의대)

13:56 - 14:03

Low-density lipoprotein cholesterol level, statin use & myocardial infarction risk in young adults

김미경 (가톨릭의대)

14:03 - 14:28

Q&A

September 17(Sat)
14:45 - 16:15
Symposium 20
How will new technologies change our research & patient care in ASCVD?
September 17(Sat) 14:45 - 16:15
Symposium 20
How will new technologies change our research & patient care in ASCVD?

Chairpersons

한승환 (가천의대), 김대중 (아주의대)

Panels

이준원(연세의대), 주형준(고려의대)

14:45 - 15:05

Tips for performing nationwide big cohort studies

양필성 (차의대)

15:05 - 15:25

Advance of AI utility in past 5 years in ASCVD care: overview

조준환 (중앙의대)

15:25 - 15:45

Novel electrocardiogram generating technique using artificial intelligence: from 2-lead to 12-lead

이학승 (메디컬에이아이)

15:45 - 16:10

Discussion

Breakfast & Luncheon Symposium
September 17(Sat)
08:00 - 09:00
Breakfast Symposium 3 [Yuhan]
September 17(Sat) 08:00 - 09:00
Breakfast Symposium 3 [Yuhan]

Chairperson

손태서 (가톨릭의대)

Panels

김정수 (부산의대), 전성완 (순천향의대)

08:00 - 08:20

A new paradigm of combination therapy in hypercholesterolemia treatment: rosuvastatin & ezetimibe

김병진 (성균관의대)

08:20 - 08:30

Discussion

September 17(Sat)
12:05 - 12:55
Luncheon Symposium 7 [Inno.N]
September 17(Sat) 12:05 - 12:55
Luncheon Symposium 7 [Inno.N]

Chairperson

이현철 (연세이현철내과)

Panels

박형복 (가톨릭관동대), 서미혜 (순천향의대)

12:05 - 12:25

Treatment of dyslipidemia with rosuvastatin & ezetimibe

김상현 (서울의대)

12:25 - 12:35

Discussion

September 17(Sat)
09:00 - 09:40
Plenary Lecture 4
September 17(Sat) 09:00 - 09:40
Plenary Lecture 4

Chairperson

Joong-Yeol Park (University of Ulsan, Korea)

09:00 - 09:40

Effect of alirocumab in subjects with likely familial hypercholesterolemia or type III hyperlipidemia: analyses from the ODYSSEY outcomes study

Sergio Fazio (Regeneron Pharmaceuticals, USA)

September 17(Sat)
09:45 - 11:15
Symposium 17
Emerging targets & drug platforms in dyslipidemia & atherosclerosis
September 17(Sat) 09:45 - 11:15
Symposium 17 Emerging targets & drug platforms in dyslipidemia & atherosclerosis

Chairpersons

Kyong Soo Park (Seoul National University, Korea), Alan Remaley (National Institute of Health, USA)

Panels

Gyuri Kim (Sunkyunkwan University, Korea), Chang-Hoon Woo (Yeungnam University, Korea)

09:45 - 10:05

Impact of lipases on human dyslipidemia & atherosclerosis

Hayato Tada (Kanazawa University, Japan)

10:05 - 10:25

Discover of new genes involved in low-density lipoprotein metabolism by genome-wide CRISPR-Cas9 screens

Alan Remaley (National Institutes of Health, USA)

10:25 - 10:45

Development of a GalNAc-asiRNA for treatment of NASH with fibrosis

Dong Ki Lee (OliX Pharmaceuticals, Korea)

10:45 - 11:10

Discussion

September 17(Sat)
11:25 - 12:05
Plenary Lecture 5
September 17(Sat) 11:25 - 12:05
Plenary Lecture 5

Chairperson

Ki Hoon Han (University of Ulsan, Korea)

11:25 - 12:05

Best approach to cardio & cerebrovascular health in older people

Hidenori Arai (National Center for Geriatrics and Gerontology, Japan)

September 17(Sat)
13:00 - 13:30
Plenary Lecture 6 (APSAVD:Yamamoto Lecture)
September 17(Sat) 13:00 - 13:30
Plenary Lecture 6 (APSAVD:Yamamoto Lecture)

Chairperson

Richard O’Brien (University of Melbourne, Australia)

13:00 - 13:30

Up close & personal with vascular diseases: the role of precision medicine

Maria Teresa Abola (University of Philippines, Philippines)

September 17(Sat)
13:35 - 14:35
Oral Presentation 5
September 17(Sat) 13:35 - 14:35
Oral Presentation 5

Chairperson

Eun Seok Kang (Yonsei University, Korea)

Panels

Yong-ho Lee (Yonsei University, Korea)

13:35 - 13:42

Ginsenoside Rh1 abolishes ROS-dependent KLF4 signaling pathway to inhibit proliferation & migration of vascular smooth muscle cells

Diem Thi Ngoc Huynh (Chungnam National University, Korea)

13:42 - 13:49

PCSK9 inhibitors inhibit monocyte adherence to stimulated human coronary artery endothelial cells

Rahayu Zulkapli (Universiti Teknologi MARA, Malaysia)

13:49 - 13:56

Lipoprotein(a) & cardiovascular & all-cause mortality in Korean adults 

Byung Jin Kim (Sungkyunkwan University, Korea)

13:56 - 14:03

Saffron: a potential natural alternative remedy for statin intolerance

Iman Nabilah Abd Rahim (Universiti Teknologi MARA, Malaysia)

14:03 - 14:28

Q&A

September 17(Sat)
14:45 - 16:15
Symposium 21
New concepts in vascular biology
September 17(Sat) 14:45 - 16:15
Symposium 21 New concepts in vascular biology

Chairpersons

김치대 (부산대), 국현 (전남대)

Panels

진은선 (경희의대), 허진 (부산대)

14:45 - 15:05

What’s the role of mitochondrial dysfunction in pathogenesis of vascular calcification?

이인규 (경북의대)

15:05 - 15:25

Senotherapeutics; a novel strategy for atherosclerosis

김재룡 (영남대)

15:25 - 15:45

Extracellular vesicles in endothelial cells: from inter-cellular communication to cargo delivery tools

권기환 (이화의대)

15:45 - 16:10

Discussion

Breakfast & Luncheon Symposium
September 17(Sat)
08:00 - 09:00
Breakfast Symposium 4 [JW Pharmaceutical]
September 17(Sat) 08:00 - 09:00
Breakfast Symposium 4 [JW Pharmaceutical]

Chairperson

Ung Kim (Yeungnam University, Korea)

Panel

Kyung-Soo Kim (CHA University, Korea), Jae Hyuk Choi (Hallym University, Korea)

08:00 - 08:20

Management of poorly controlled patients with diabetes mellitus

Yong-ho Lee (Yonsei University, Korea)

08:20 - 08:30

Discussion

September 17(Sat)
12:05 - 12:55
Luncheon Symposium 8 [Hanmi]
September 17(Sat) 12:05 - 12:55
Luncheon Symposium 8 [Hanmi]

Chairperson

서홍석 (고려의대)

Panels

김병규 (인제의대), 조윤경 (울산의대)

12:05 - 12:25

Why should we consider rosuvastatin-ezetimibe fixed dose combination?: strategies for reaching LDL goals in cardiovascular disease patients

나승운 (고려의대)

12:25 - 12:35

Discussion

September 17(Sat)
09:00 - 09:40
Plenary Lecture 4
September 17(Sat) 09:00 - 09:40
Plenary Lecture 4

Chairperson

Joong-Yeol Park (University of Ulsan, Korea)

09:00 - 09:40

Effect of alirocumab in subjects with likely familial hypercholesterolemia or type III hyperlipidemia: analyses from the ODYSSEY outcomes study

Sergio Fazio (Regeneron Pharmaceuticals, USA)

September 17(Sat)
09:45 - 11:15
Symposium 18
Role & unsolved issues of novel lipid-modifying agents
September 17(Sat) 09:45 - 11:15
Symposium 18 Role & unsolved issues of novel lipid-modifying agents

Chairpersons

Byung Jin Kim (Sungkyunkwan University, Korea), Soo Lim (Seoul National University, Korea)

Panels

Min Kyong Moon (Seoul National University, Korea), Jang Hoon Lee (Kyungpook National University, Korea)

09:45 - 10:05

Challenges & perspective of drugs for Lp(a)

Gisette Reyes-Soffer (Columbia University, USA)

10:05 - 10:25

For whom & how much will bempedoic acid work?

Raul Santos (University of São Paulo, Brazil)

10:25 - 10:45

Recent trial results of new drugs targeting TG rich lipoprotein

Eun Ho Choo (The Catholic University of Korea, Korea)

10:45 - 11:10

Discussion

September 17(Sat)
11:25 - 12:05
Plenary Lecture 5
September 17(Sat) 11:25 - 12:05
Plenary Lecture 5

Chairperson

Ki Hoon Han (University of Ulsan, Korea)

11:25 - 12:05

Best approach to cardio & cerebrovascular health in older people

Hidenori Arai (National Center for Geriatrics and Gerontology, Japan)

September 17(Sat)
13:00 - 13:30
Plenary Lecture 6 (APSAVD:Yamamoto Lecture)
September 17(Sat) 13:00 - 13:30
Plenary Lecture 6 (APSAVD:Yamamoto Lecture)

Chairperson

Richard O’Brien (University of Melbourne, Australia)

13:00 - 13:30

Up close & personal with vascular diseases: the role of precision medicine

Maria Teresa Abola (University of Philippines, Philippines)

September 17(Sat)
14:45 - 16:15
Symposium 22 (TSLA/KSoLA Joint Symposium)
Sex difference in dyslipidemia & atherosclerosis
September 17(Sat) 14:45 - 16:15
Symposium 22 (TSLA/KSoLA Joint Symposium) Sex difference in dyslipidemia & atherosclerosis

Chairpersons

Sang-Hyun Kim (Seoul National University, Korea), Chul Sik Kim (Yonsei University, Korea)

Panels

Sung-Eun Kim (Hallym University, Korea), Sang Min Park (Eulji University, Korea)

14:45 - 15:05

Characteristics of dyslipidemia & ASCVD of women

Mi-Na Kim (Korea University, Korea)

15:05 - 15:25

Gender difference in cardiovascular disease: focus on antiplatelet therapy

Ping-Yen Liu (National Cheng Kung University, Taiwan)

15:25 - 15:45

Is there difference of response to lipid-lowering therapy in women?

Chih-Fan Yeh (National Taiwan University, Taiwan)

15:45 - 16:10

Discussion

Breakfast & Luncheon Symposium
September 17(Sat)
12:05 - 12:55
Luncheon Symposium 9 [Amgen]
September 17(Sat) 12:05 - 12:55
Luncheon Symposium 9 [Amgen]

Chairperson

Kyong Soo Park (Seoul National University, Korea)

Panels

Eu Jeong Ku (Chungbuk National University, Korea), Choongki Kim (Ewha Womans University, Korea)

12:05 - 12:25

Key updates in the recent guidelines – identifying patients for evolocumab therapy

Wonjae Lee (Seoul National University, Korea)

12:25 - 12:35

Discussion

September 17(Sat)
09:45 - 11:15
Symposium 19
Current nutritional knowledge in cardiometabolic health
September 17(Sat) 09:45 - 11:15
Symposium 19 Current nutritional knowledge in cardiometabolic health

Chairpersons

Kee Ho Song (Konkuk University, Korea)

Panels

In-Jeong Cho (Ewha Womans University, Korea), Jeong-Hwa Choi (Keimyung University, Korea)

09:45 - 10:05

Organ crosstalk under atherogenic diet

Cholsoon Jang (University of California Irvine, USA)

10:05 - 10:25

Emerging role of epigenetic regulation by nutrients in inflammation & atherosclerosis

Hyunju Kang (Keimyung University, Korea)

10:25 - 10:45

Transition to metabolically unhealthy status & cardiometabolic risks

Clara Yongjoo Park (Chonnam National University, Korea)

10:45 - 11:10

Discussion

September 17(Sat)
14:45 - 16:15
Symposium 23 (APSAVD Joint Symposium)
Update on antibodies & siRNA against PCSK9
September 17(Sat) 14:45 - 16:15
Symposium 23 (APSAVD Joint Symposium)
Update on antibodies & siRNA against PCSK9

Chairpersons

In-Kyung Jeong (Kyung Hee University, Korea), Hapizah Mohd Nawawi (Universiti Teknologi MARA, Malaysia)

Panels

Hyun Jae Kang (Seoul National University, Korea), Jong-Young Lee (Sungkyunkwan University, Korea)

14:45 - 15:05

Practical approach of PCSK9 Ab use in primary & secondary prevention

Young Joon Hong (Chonnam National University, Korea)

15:05 - 15:25

Comparison of two drug platforms for PCSK9 inhibition (Monoclonal antibodies & siRNA)

Richard O’Brien (University of Melbourne, Australia)

15:25 - 15:45

Patients who are resistant to or hypo-respond to PCSK9 inhibitors – a therapeutic challenge

Edward Janus (University of Melbourne, Australia)

15:45 - 16:10

Discussion

Breakfast & Luncheon Symposium
September 17(Sat)
12:05 - 12:55
Luncheon Symposium 10 [Sanofi]
September 17(Sat) 12:05 - 12:55
Luncheon Symposium 10 [Sanofi]

Chairperson

In-Kyu Lee (Kyungpook National University, Korea)

Panels

Jae Hyun Bae (Korea University, Korea), Sang-Hun Shin (Ewha Womans University, Korea)

12:05 - 12:25

The time for intensive lipid lowering therapy in very high-risk patients based on the updated Korean guideline

Hoyoun Won (Chung-Ang University, Korea)

12:25 - 12:35

Discussion

September 16(Fri)
13:35 - 14:15
Moderated Poster Presentation 3
September 16(Fri) 13:35 - 14:15
Moderated Poster Presentation 3

Chairperson

전성완(순천향의대)

Panels

김경수(차의대), 최한석(동국의대)

13:35 - 13:43

Autocrine regulation of cellular migration by secreted molecules from mechanically stressed vascular smooth muscle cells 

김주연 (부산대)

13:43 - 13:51

Depression & subclinical coronary atherosclerosis in adults without clinical coronary artery disease

박경민 (울산대)

13:51 - 13:59

Effect of lifestyle modification on the improvement of obesity, metabolic parameters & adipo-myokine related risk in overweight/obese adults

하미리 (동아대)

September 16(Fri)
13:35 - 14:15
Moderated Poster Presentation 4
September 16(Fri) 13:35 - 14:15
Moderated Poster Presentation 4

Chairperson

Su Yeon Choi (Seoul National University, Korea)

Panels

Hoyoun Won (Chung-Ang University, Korea), Kae Won Cho (Soonchunhyang University, Korea)

13:35 - 13:43

Mutation in CytB gene associated with macrophage intracellular lipid metabolism

Vasily Sukhorukov (Institute for Atherosclerosis Research, Russia)

13:43 - 13:51

Human milk oligosaccharides attenuate lipopolysaccharide-induced endothelial hyper-permeability & migration

Dung Van Nguyen (Chungnam National University, Korea)

13:51 - 13:59

Modeling of low-density lipoprotein desialylation processes in mice

Dmitry Kashirskikh (Petrovsky National Research Centre of Surgery, Russia)

13:59 - 14:07

Tyrosine Residues of mitochondrial creatine kinase mitigate hypoxia/reoxygenation injury in the heart through phosphorylation

Maria Victoria Faith Garcia (Cardiovascular and Metabolic Disease Center, Korea)

Sponsored by